Latest news with #PBFintechLimited
Business Insider
11 hours ago
- Business
- Business Insider
Citi Sticks to Their Buy Rating for PB Fintech Limited (POLICYBZR)
Citi analyst Dipanjan Ghosh maintained a Buy rating on PB Fintech Limited (POLICYBZR – Research Report) on June 5 and set a price target of INR2,185.00. The company's shares closed last Friday at INR1,916.70. Confident Investing Starts Here: According to TipRanks, Ghosh is a 3-star analyst with an average return of 9.0% and a 72.22% success rate. Ghosh covers the Financial sector, focusing on stocks such as Go Digit General Insurance Limited, ICICI Lombard General Insurance Co. Ltd., and ICICI Prudential Life Insurance Co. Ltd.. In addition to Citi, PB Fintech Limited also received a Buy from Investec's Nidhesh Jain in a report issued on May 25. However, on May 28, UBS maintained a Sell rating on PB Fintech Limited (NSE: POLICYBZR).
Business Upturn
24-04-2025
- Business
- Business Upturn
PB Fintech invests Rs 539 crore in PB Healthcare; stake to reduce to 32.14% after external funding round
By Aditya Bhagchandani Published on April 24, 2025, 19:19 IST PB Fintech Limited, the parent company of Policybazaar, has announced a ₹539.40 crore investment in its wholly-owned subsidiary PB Healthcare Services Private Limited, as part of the first tranche of a seed funding round. The funding aligns with the company's earlier shareholder approval of up to ₹696 crore, secured through a postal ballot on April 15, 2025. The seed round totals ₹1,461.60 crore, with participation from PB Fintech and external investors. As a result of the fresh capital infusion and the creation of an Employee Stock Option Plan (ESOP) pool, PB Fintech's stake in PB Healthcare will reduce from 100% to 32.14% on a fully diluted basis. PB Healthcare, incorporated on January 1, 2025, operates in the healthcare and allied services sector. The investment aims to strengthen the subsidiary's financial foundation and support future growth. The funding was executed through the allotment of 5,39,40,000 Compulsory Convertible Preference Shares (CCPS) at ₹100 per share. The transaction is classified as a related-party deal but was conducted at fair market value, as determined by a registered valuer. PB Fintech stated that the dilution is a strategic step to bring in long-term investors and build a robust team via ESOPs. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always consult a financial advisor before making investment decisions. Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
